Brevan Howard Capital Management »

Arcutis Biotherapeutics shares owned by Brevan Howard Capital Management

Quarter-by-quarter ownership of Arcutis Biotherapeutics (ARQT) shares owned by Brevan Howard Capital Management from 13F filings

Historical chart of Brevan Howard Capital Management investment in Arcutis Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Arcutis Biotherapeutics held by Brevan Howard Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcutis Biotherapeutics by Brevan Howard Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $327k 35k 9.30
2024-06-30 $817k 88k 9.30
2023-12-31 $166k 51k 3.23

More positions owned by Brevan Howard Capital Management

Select Sector Spdr Tr Financial (XLF)
Ishares Tr Msci Emg Mkt Etf (EEM)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Microsoft Corporation (MSFT)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Select Sector Spdr Tr Sbi Int-utils (XLU)
Vaneck Etf Trust Gold Miners Etf (GDX)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Select Sector Spdr Tr Sbi Healthcare Call Option (XLV)
Ishares Tr Russell 2000 Etf (IWM)
Alibaba Group Hldg Sponsored Ads (BABA)
Ishares Ethereum Tr SHS (ETHA)
Newmont Mining Corporation Call Option (NEM)
Select Sector Spdr Tr Technology Call Option (XLK)

View all positions for Brevan Howard Capital Management

Top funds holding Arcutis Biotherapeutics

Jennison Associates
Suvretta Capital Management
Rubric Capital Management
BlackRock
Frazier Life Sciences Management
Polar Capital Holdings
Vanguard Group
State Street Corporation
Morgan Stanley
Gilder, Gagnon, Howe & Co
Franklin Resources
UBS Group
D. E. Shaw & Co
Geode Capital Management
Ensign Peak Advisors

View all funds holding Arcutis Biotherapeutics